Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 8.0B | 4.9B | 5.1B | 5B |
Cost of revenue | 5.0B | 2.9B | 2.9B | 2.9B |
Gross profit | 3.0B | 2.0B | 2.2B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.4B | 2.1B | 2.0B | 1.9B |
Other operating expenses | — | — | — | — |
Operating income | 634M | -25M | 185M | 143M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 21M | 32M | 31M | 31M |
Other income expense | -177M | 92M | 41M | -14M |
Pretax income | 436M | 35M | 195M | 98M |
Tax provision | 94M | 7M | 45M | 36M |
Net income | 342M | 28M | 150M | 62M |
Basic EPS | 1.2 | 0.1 | 0.5 | 0.2 |
Diluted EPS | 1.2 | 0.1 | 0.5 | 0.2 |
Basic average shares | 14.4M | 14.4M | 14.4M | 14.3M |
Diluted average shares | 14.6M | 14.5M | 14.6M | 14.5M |
EBITDA | 816M | 207M | 402M | 363M |
Net income from continuing op. | 342M | 28M | 150M | 62M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |